We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Whole lung lavage and GM-CSF use for pulmonary alveolar proteinosis in an infant with lysinuric protein intolerance: a case report

    Background

    Lysinuric protein intolerance (LPI) is a multi-organ metabolic disorder characterized by the imbalance in absorption and excretion of...

    Eszter Vojcek, Dóra Krikovszky, ... Attila J. Szabó in Italian Journal of Pediatrics
    Article Open access 03 June 2024
  2. CSF hypersecretion versus impaired CSF absorption in posthemorrhagic hydrocephalus: a systematic review

    Background

    The molecular mechanisms underlying development of posthemorrhagic hydrocephalus (PHH) remain elusive. The aim of this systematic review...

    Shai David Ben-Shoshan, Sara Diana Lolansen, ... Nanna MacAulay in Acta Neurochirurgica
    Article 29 August 2023
  3. Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis

    Background

    Chitinase -3-like 1-protein (CHI3L1) is a glycoside secreted by monocytes, microglia, and activated astrocytes. Its distribution in...

    Foraysa Talaat, Sahar Abdelatty, ... Ahmed Dahshan in Neurological Sciences
    Article Open access 29 March 2023
  4. CSF shunt valve occlusion—does CSF protein and cell count matter?

    Background

    Shunt obstruction is a common cause of shunt failure in the treatment of hydrocephalus. Valve occlusion is traditionally believed to...

    Stefanie Kaestner, Rebekka Sani, ... Wolfgang Deinsberger in Acta Neurochirurgica
    Article 03 May 2021
  5. Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma

    The clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma (ND-DLBCL) remains largely unexplored. One...

    **-Hua Liang, Yi-Fan Wu, ... Wei Xu in Leukemia
    Article 15 May 2024
  6. Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer’s disease

    Β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) is a crucial protease in the production of amyloid-β (Aβ) in Alzheimer’s disease (AD)...

    Feng Gao, Mengguo Zhang, ... Yong Shen in Acta Neuropathologica
    Article 10 June 2024
  7. Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus

    Background

    By applying an unbiased proteomic approach, we aimed to search for cerebrospinal fluid (CSF) protein biomarkers distinguishing between...

    Nina Rostgaard, Markus Harboe Olsen, ... Marianne Juhler in Acta Neurochirurgica
    Article Open access 19 October 2023
  8. PCR-positive meningococcal CSF infection without pleocytosis but high IL-6 and IL-8

    Background

    Meningococcal meningitis is still a severe disease causing high mortality and morbidity rates. Early diagnosis is crucial to ensure prompt...

    Susanne Dyckhoff-Shen, Hans-Walter Pfister, ... Matthias Klein in Infection
    Article Open access 27 April 2024
  9. Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapy

    Cryptococcal meningitis (CM) is a severe fungal disease in immunocompromised patients affecting the central nervous system (CNS). Host response and...

    Christine Dambietz, Michael Heming, ... Gerd Meyer zu Hörste in BMC Neurology
    Article Open access 03 July 2024
  10. Is blood pTau a reliable indicator of the CSF status? A narrative review

    Background

    The identification of biomarkers for the early diagnosis of Alzheimer’s disease (AD) is a crucial goal of the current research. Blood...

    Annibale Antonioni, Emanuela Maria Raho, Francesco Di Lorenzo in Neurological Sciences
    Article 22 December 2023
  11. Novel CSF biomarkers for diagnosis and integrated analysis of neuropsychiatric systemic lupus erythematosus: based on antibody profiling

    Background

    Neuropsychiatric systemic lupus erythematosus (NPSLE), with various morbidities and multiple manifestations in the central nervous system,...

    Jiali Ni, Chen Chen, ... Jun Liang in Arthritis Research & Therapy
    Article Open access 08 September 2023
  12. Serum and CSF metabolomics analysis shows Mediterranean Ketogenic Diet mitigates risk factors of Alzheimer’s disease

    Alzheimer’s disease (AD) is influenced by a variety of modifiable risk factors, including a person’s dietary habits. While the ketogenic diet (KD)...

    Annalise Schweickart, Richa Batra, ... Jan Krumsiek in npj Metabolic Health and Disease
    Article Open access 01 July 2024
  13. CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

    Post-mortem staging of Alzheimer’s disease (AD) neurofibrillary pathology is commonly performed by immunohistochemistry using AT8 antibody for...

    Juan Lantero-Rodriguez, Laia Montoliu-Gaya, ... Kaj Blennow in Acta Neuropathologica
    Article Open access 06 January 2024
  14. Trans-Nasal Endoscopic Repair of CSF Rhinorrhea: An Institutional Experience

    Introduction

    Cerebrospinal Fluid (CSF) rhinorrhea results from breakdown in the integrity of structures separating the subarachnoid space and nasal...

    Muhammad Arshad, Malik Jawad Faisal, ... Shahzaib Maqbool in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 13 October 2023
  15. Neurodegeneration or dysfunction in Phelan-McDermid syndrome? A multimodal approach with CSF and computational MRI

    Background

    Phelan-McDermid syndrome (PMS) is a rare multisystem disease with global developmental delay and autistic features. Genetically, the...

    Sarah Jesse, Hans-Peter Müller, ... Jan Kassubek in Orphanet Journal of Rare Diseases
    Article Open access 05 September 2023
  16. Neuropathological hints from CSF and serum biomarkers in corticobasal syndrome (CBS): a systematic review

    Corticobasal syndrome (CBS) is a clinical syndrome determined by various underlying neurodegenerative disorders requiring a pathological assessment...

    Giulia Remoli, Edoardo Dalmato Schilke, ... Ildebrando Appollonio in Neurological Research and Practice
    Article Open access 04 January 2024
  17. Temporal Changes in CSF Cell Parameters After SAH: Comparison of Ventricular and Spinal Drain Samples

    Background

    Forty percent of patients with aneurysmatic subarachnoid hemorrhage (aSAH) develop acute hydrocephalus requiring treatment with...

    Jyri J. Virta, Jarno Satopää, ... Rahul Raj in Neurocritical Care
    Article Open access 14 February 2024
  18. Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

    Background

    Clusterin is a multifunctional protein, which is associated with the pathogenesis and the development of Alzheimer’s disease (AD). Compared...

    Lian Tang, Zhi-Bo Wang, ... Meng-Shan Tan in BMC Neurology
    Article Open access 30 December 2022
  19. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease

    Parkinson’s disease (PD) starts at the molecular and cellular level long before motor symptoms appear, yet there are no early-stage molecular...

    Jarod Rutledge, Benoit Lehallier, ... Kathleen L. Poston in Acta Neuropathologica
    Article Open access 11 March 2024
  20. Bile acid profile associated with CSF and PET biomarkers in Alzheimer’s disease

    Background

    Recent studies have shown that gut microbiota can affect the development of Alzheimer’s disease (AD) through various mechanisms. Bile acids...

    Fardin Nabizadeh, Parya Valizadeh, Mohammad Sadegh Fallahi in Aging Clinical and Experimental Research
    Article Open access 07 March 2024
Did you find what you were looking for? Share feedback.